These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 2481789

  • 1. Pharmacology of third-generation beta-blockers: greater benefits, fewer risks.
    Kendall MJ.
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S4-8. PubMed ID: 2481789
    [Abstract] [Full Text] [Related]

  • 2. Do we need a new classification of beta-blockers?
    Kendall MJ.
    J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
    [Abstract] [Full Text] [Related]

  • 3. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ, Heaton PC, Cluxton RJ.
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [Abstract] [Full Text] [Related]

  • 4. Celiprolol and risk factor reversal in hypertension.
    Taylor SH.
    J Cardiovasc Pharmacol; 1989 Feb; 14 Suppl 7():S33-9. PubMed ID: 2481788
    [Abstract] [Full Text] [Related]

  • 5. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.
    Bell DS.
    Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528
    [Abstract] [Full Text] [Related]

  • 6. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E, Heikkilä J.
    Ann Clin Res; 1988 Aug; 20(5):324-33. PubMed ID: 2905877
    [Abstract] [Full Text] [Related]

  • 7. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The evolving role of calcium channel blockers in the treatment of angina pectoris: focus on felodipine.
    Gradman AH.
    Can J Cardiol; 1995 Apr; 11 Suppl B():14B-21B. PubMed ID: 7728649
    [Abstract] [Full Text] [Related]

  • 10. Celiprolol--overview of 6 years of clinical trials experience.
    Pruss TP, Lamon KD, Hagen NS.
    J Int Med Res; 1988 Apr; 16 Suppl 1():17A-22A. PubMed ID: 2906015
    [Abstract] [Full Text] [Related]

  • 11. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotection with beta-blockers: myths, facts and Pascal's wager.
    Messerli FH, Bangalore S, Yao SS, Steinberg JS.
    J Intern Med; 2009 Sep; 266(3):232-41. PubMed ID: 19702791
    [Abstract] [Full Text] [Related]

  • 13. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.
    Kuti EL, Baker WL, White CM.
    Curr Med Res Opin; 2007 Jun; 23(6):1239-44. PubMed ID: 17559720
    [Abstract] [Full Text] [Related]

  • 14. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
    Dotzer F, Gromer H.
    Fortschr Med; 1993 Aug 30; 111(24):382-4. PubMed ID: 8104853
    [Abstract] [Full Text] [Related]

  • 15. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O, Johansson BW.
    J Hypertens Suppl; 1993 Jun 30; 11(4):S55-60. PubMed ID: 8104242
    [Abstract] [Full Text] [Related]

  • 16. Comprehensive drug management of angina pectoris.
    Pepine CJ, Feldman RL, Conti CR.
    Cardiovasc Clin; 1984 Jun 30; 14(3):139-51. PubMed ID: 6144388
    [Abstract] [Full Text] [Related]

  • 17. A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.
    Kendall MJ, Rajman I.
    Drug Saf; 1994 Mar 30; 10(3):220-32. PubMed ID: 7913813
    [Abstract] [Full Text] [Related]

  • 18. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P, Sarsero D, Arch JR, Kelly J, Henson SM, Kaumann AJ.
    Br J Pharmacol; 1997 Jan 30; 120(2):165-76. PubMed ID: 9117106
    [Abstract] [Full Text] [Related]

  • 19. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I, Edes I.
    Orv Hetil; 2004 Sep 19; 145(38):1951-60. PubMed ID: 15535106
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.